Anteotech Ltd (ADO:ASX)


right-arrow Created with Sketch. 0 (0%)
MCAP $482.7M
Last trade 16.10pm 20/10/2021 20mins delayed

Latest Announcements

11/10/2021ADOAnteotech Ltd
23/09/2021ADOAnteotech Ltd
23/09/2021 Price SensitivePSADOAnteotech Ltd
23/09/2021 Price SensitivePSADOAnteotech Ltd
21/09/2021ADOAnteotech Ltd
17/09/2021ADOAnteotech Ltd
16/09/2021 Price SensitivePSADOAnteotech Ltd
06/09/2021 Price SensitivePSADOAnteotech Ltd

Company Overview

AnteoTech Limited is an Australia-based surface chemistry company. The Company is focused on the development and commercialization of its intellectual property of specialized surfaces used in the life sciences, diagnostics, energy and medical devices markets. The Company's products include AnteoCoat, AnteoBind and AnteoRelease, which are used in the energy, diagnostic and medical device markets. The Company's AnteoBind is an aqueous nanosized molecular glue (polymeric metal ions) used in a single-step process to facilitate multivalent coordination to bind carbohydrate polymers, antibodies, and proteins to synthetic substrates in assay development. The Company is also developing, SARS-CoV-2 Ag rapid test, which is a single-use, disposable, lateral flow test for the qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasopharyngeal specimens collected from individuals who are suspected of COVID-19 infection.

ADO in the news

AnteoTech (ADO) is looking to obtain Australian Therapeutic Goods Administration approval for…
AnteoTech (ADO) signs an agreement with Ramma Dental to exclusively distribute two…
AnteoTech (ADO) signs a distribution agreement for its EuGeni reader platform and…
AnteoTech (ADO) signs a distribution agreement with UC Biosciences for its EuGeni…

Search Previous Announcements